Dr. Tripathy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1516 Holcombe Boulevard
CPB5.3405
Houston, TX 77030Phone+1 713-792-2817Fax+1 713-563-0903
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1988 - 1992
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1989 - 1991
- Duke University HospitalResidency, Internal Medicine, 1986 - 1988
- Duke University School of MedicineClass of 1985
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- GA State Medical License 2023 - 2026
- OK State Medical License 2020 - 2026
- AL State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer.Linjie Luo, Peng Yang, Sofia Mastoraki, Xiayu Rao, Yan Wang
Molecular Cancer. 2025-02-15 - Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models.Funda Meric-Bernstam, Erkan Yuca, Kurt W Evans, Ming Zhao, Takanori Maejima
Clinical Cancer Research. 2025-02-03 - 1 citationsReal-world quality-of-life of patients with HR+/HER2- advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS.Gabrielle B Rocque, Joanne L Blum, Yan Ji, Timothy Pluard, John Migas
Breast Cancer Research and Treatment. 2025-02-01
Press Mentions
- MD Anderson Research Highlights for February 10, 2025February 10th, 2025
- Scientists Share ‘Comprehensive’ Map of Volcanoes on Venus — All 85,000 of ThemMarch 28th, 2023
- Mount Sinai Health System Recognized by Fortune as One of “America’s Most Innovative Companies 2023”March 28th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: